Role of Alfuzosin in Ureteral Stent Related Urinary Symptoms Score: A Comparative Study

Background: Ureteral stent placement is a routine urological procedure. However, patients inserted with ureteral stent exhibited increased urinary symptoms that compromise patients’ quality of life. Objective: To assess the efficacy of alpha blockers (Alfuzosin) in the management of ureteral stent r...

Full description

Bibliographic Details
Main Authors: Santosh Shrestha, DB Adhikari, A Gurung, S Pradhan, NV Gurung, A Acharya, D Shrestha, SR Poudel, A Chapagain, P Lamichhane
Format: Article
Language:English
Published: Gandaki Medical College Teaching Hospital & Research Centre Pvt. Ltd. 2017-08-01
Series:Journal of Gandaki Medical College
Subjects:
Online Access:https://www.nepjol.info/index.php/JGMCN/article/view/17912
_version_ 1797449661375578112
author Santosh Shrestha
DB Adhikari
A Gurung
S Pradhan
NV Gurung
A Acharya
D Shrestha
SR Poudel
A Chapagain
D Shrestha
P Lamichhane
author_facet Santosh Shrestha
DB Adhikari
A Gurung
S Pradhan
NV Gurung
A Acharya
D Shrestha
SR Poudel
A Chapagain
D Shrestha
P Lamichhane
author_sort Santosh Shrestha
collection DOAJ
description Background: Ureteral stent placement is a routine urological procedure. However, patients inserted with ureteral stent exhibited increased urinary symptoms that compromise patients’ quality of life. Objective: To assess the efficacy of alpha blockers (Alfuzosin) in the management of ureteral stent related urinary symptoms. Methods: Total of 60 patients after ureteral stent insertion was randomly divided into two equal groups; 30 in alfuzosin group and the remaining 30 in control group. Urinary symptoms questionnaire was filled after two weeks and results were statistically analyzed. Results: Urinary symptoms like urgency, frequency and flank pain were significantly less in the alfuzosin group when compared with control group. Conclusion: Alpha blocker (Alfuzosin) was found to be effective in reducing ureteral stent related urinary symptoms. Journal of Gandaki Medical College Vol. 10, No. 1, 2017, page: 28-30
first_indexed 2024-03-09T14:29:16Z
format Article
id doaj.art-efb8779e873d4376a33253a2ed405ab5
institution Directory Open Access Journal
issn 2070-4240
2070-4259
language English
last_indexed 2024-03-09T14:29:16Z
publishDate 2017-08-01
publisher Gandaki Medical College Teaching Hospital & Research Centre Pvt. Ltd.
record_format Article
series Journal of Gandaki Medical College
spelling doaj.art-efb8779e873d4376a33253a2ed405ab52023-11-28T04:59:52ZengGandaki Medical College Teaching Hospital & Research Centre Pvt. Ltd.Journal of Gandaki Medical College2070-42402070-42592017-08-01101283010.3126/jgmcn.v10i1.1791217912Role of Alfuzosin in Ureteral Stent Related Urinary Symptoms Score: A Comparative StudySantosh Shrestha0DB Adhikari1A Gurung2S Pradhan3NV Gurung4A Acharya5D Shrestha6SR Poudel7A Chapagain8D Shrestha9P Lamichhane10Department of Surgery, Western Regional Hospital, PokharaDepartment of Surgery, Western Regional Hospital, PokharaDepartment of Surgery, Western Regional Hospital, PokharaDepartment of Surgery, Western Regional Hospital, PokharaDepartment of Surgery, Western Regional Hospital, PokharaDepartment of Surgery, Western Regional Hospital, PokharaDepartment of Surgery, Western Regional Hospital, PokharaDepartment of Surgery, Western Regional Hospital, PokharaDepartment of Surgery, Western Regional Hospital, PokharaDepartment of Surgery, Western Regional Hospital, PokharaDepartment of Microbiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, BangkokBackground: Ureteral stent placement is a routine urological procedure. However, patients inserted with ureteral stent exhibited increased urinary symptoms that compromise patients’ quality of life. Objective: To assess the efficacy of alpha blockers (Alfuzosin) in the management of ureteral stent related urinary symptoms. Methods: Total of 60 patients after ureteral stent insertion was randomly divided into two equal groups; 30 in alfuzosin group and the remaining 30 in control group. Urinary symptoms questionnaire was filled after two weeks and results were statistically analyzed. Results: Urinary symptoms like urgency, frequency and flank pain were significantly less in the alfuzosin group when compared with control group. Conclusion: Alpha blocker (Alfuzosin) was found to be effective in reducing ureteral stent related urinary symptoms. Journal of Gandaki Medical College Vol. 10, No. 1, 2017, page: 28-30https://www.nepjol.info/index.php/JGMCN/article/view/17912alfuzosinalpha blockerureteral stenturinary symptoms
spellingShingle Santosh Shrestha
DB Adhikari
A Gurung
S Pradhan
NV Gurung
A Acharya
D Shrestha
SR Poudel
A Chapagain
D Shrestha
P Lamichhane
Role of Alfuzosin in Ureteral Stent Related Urinary Symptoms Score: A Comparative Study
Journal of Gandaki Medical College
alfuzosin
alpha blocker
ureteral stent
urinary symptoms
title Role of Alfuzosin in Ureteral Stent Related Urinary Symptoms Score: A Comparative Study
title_full Role of Alfuzosin in Ureteral Stent Related Urinary Symptoms Score: A Comparative Study
title_fullStr Role of Alfuzosin in Ureteral Stent Related Urinary Symptoms Score: A Comparative Study
title_full_unstemmed Role of Alfuzosin in Ureteral Stent Related Urinary Symptoms Score: A Comparative Study
title_short Role of Alfuzosin in Ureteral Stent Related Urinary Symptoms Score: A Comparative Study
title_sort role of alfuzosin in ureteral stent related urinary symptoms score a comparative study
topic alfuzosin
alpha blocker
ureteral stent
urinary symptoms
url https://www.nepjol.info/index.php/JGMCN/article/view/17912
work_keys_str_mv AT santoshshrestha roleofalfuzosininureteralstentrelatedurinarysymptomsscoreacomparativestudy
AT dbadhikari roleofalfuzosininureteralstentrelatedurinarysymptomsscoreacomparativestudy
AT agurung roleofalfuzosininureteralstentrelatedurinarysymptomsscoreacomparativestudy
AT spradhan roleofalfuzosininureteralstentrelatedurinarysymptomsscoreacomparativestudy
AT nvgurung roleofalfuzosininureteralstentrelatedurinarysymptomsscoreacomparativestudy
AT aacharya roleofalfuzosininureteralstentrelatedurinarysymptomsscoreacomparativestudy
AT dshrestha roleofalfuzosininureteralstentrelatedurinarysymptomsscoreacomparativestudy
AT srpoudel roleofalfuzosininureteralstentrelatedurinarysymptomsscoreacomparativestudy
AT achapagain roleofalfuzosininureteralstentrelatedurinarysymptomsscoreacomparativestudy
AT dshrestha roleofalfuzosininureteralstentrelatedurinarysymptomsscoreacomparativestudy
AT plamichhane roleofalfuzosininureteralstentrelatedurinarysymptomsscoreacomparativestudy